104 related articles for article (PubMed ID: 28566646)
21. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
Cockeran R; Anderson R; Feldman C
Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
[TBL] [Abstract][Full Text] [Related]
22. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
Sourav S; Patricia A; Sharma S; Kanungo R; Jayachandran S; Prashanth K
Indian J Med Microbiol; 2010; 28(1):34-9. PubMed ID: 20061761
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory Effect of the Traditional Chinese Medicine Ephedra sinica granules on Streptococcus pneumoniae Pneumolysin.
Xu Y; Wei L; Wang Y; Ding L; Guo Y; Sun X; Kong Y; Guo L; Guo T; Sun L
Biol Pharm Bull; 2020; 43(6):994-999. PubMed ID: 32475921
[TBL] [Abstract][Full Text] [Related]
24. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
[TBL] [Abstract][Full Text] [Related]
25. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.
Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R
Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540
[TBL] [Abstract][Full Text] [Related]
26. Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.
Luong TT; Kim EH; Bak JP; Nguyen CT; Choi S; Briles DE; Pyo S; Rhee DK
Infect Immun; 2015 Jan; 83(1):108-19. PubMed ID: 25312953
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of pneumolysin to pulmonary endothelial cells in vitro.
Rubins JB; Duane PG; Charboneau D; Janoff EN
Infect Immun; 1992 May; 60(5):1740-6. PubMed ID: 1563759
[TBL] [Abstract][Full Text] [Related]
28. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
Anderson R; Steel HC; Cockeran R; Smith AM; von Gottberg A; de Gouveia L; Brink A; Klugman KP; Mitchell TJ; Feldman C
J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
[TBL] [Abstract][Full Text] [Related]
29. Corilagin: A Novel Antivirulence Strategy to Alleviate
Sheng Q; Hou X; Wang N; Liu M; Zhu H; Deng X; Liang X; Chi G
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014299
[TBL] [Abstract][Full Text] [Related]
30. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis.
Friedland IR; Paris MM; Hickey S; Shelton S; Olsen K; Paton JC; McCracken GH
J Infect Dis; 1995 Sep; 172(3):805-9. PubMed ID: 7658074
[TBL] [Abstract][Full Text] [Related]
31. Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation.
Shoma S; Tsuchiya K; Kawamura I; Nomura T; Hara H; Uchiyama R; Daim S; Mitsuyama M
Infect Immun; 2008 Apr; 76(4):1547-57. PubMed ID: 18195026
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae.
Lock RA; Paton JC; Hansman D
Microb Pathog; 1988 Dec; 5(6):461-7. PubMed ID: 3149709
[TBL] [Abstract][Full Text] [Related]
33. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.
Ng EW; Samiy N; Rubins JB; Cousins FV; Ruoff KL; Baker AS; D'Amico DJ
Retina; 1997; 17(6):521-9. PubMed ID: 9428015
[TBL] [Abstract][Full Text] [Related]
34. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin.
Mutepe ND; Cockeran R; Steel HC; Theron AJ; Mitchell TJ; Feldman C; Anderson R
Eur Respir J; 2013 Feb; 41(2):392-5. PubMed ID: 22743667
[TBL] [Abstract][Full Text] [Related]
35. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.
Jounblat R; Kadioglu A; Mitchell TJ; Andrew PW
Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795
[TBL] [Abstract][Full Text] [Related]
36. Magnesium therapy improves outcome in Streptococcus pneumoniae meningitis by altering pneumolysin pore formation.
Hupp S; Ribes S; Seele J; Bischoff C; Förtsch C; Maier E; Benz R; Mitchell TJ; Nau R; Iliev AI
Br J Pharmacol; 2017 Dec; 174(23):4295-4307. PubMed ID: 28888095
[TBL] [Abstract][Full Text] [Related]
37. Dryocrassin ABBA ameliorates Streptococcus pneumoniae-induced infection in vitro through inhibiting Streptococcus pneumoniae growth and neutralizing pneumolysin activity.
Lv H; Fang T; Kong F; Wang J; Deng X; Yu Q; Sun M; Liang X
Microb Pathog; 2021 Jan; 150():104683. PubMed ID: 33309685
[TBL] [Abstract][Full Text] [Related]
38. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
39. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
[TBL] [Abstract][Full Text] [Related]
40. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
Ferreira DM; Arêas AP; Darrieux M; Leite LC; Miyaji EN
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
